Company
Pep-Therapy
Unlock cells. Deliver innovation.
Also known as SAS PEP-Therapy
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Évry-Courcouronnes, France
- Customers
- pharma and biotech partners, clinical organizations and investors
- Legal name
- SAS PEP-Therapy
Claim, correct or request removal
Record updated 18 September 2026
About
PEP-Therapy is currently strengthening its pipeline of peptide-based products in oncology through co-developments or licensing-in programs with academic institutions and biotech companies.
Funding snapshot
- Latest round
- Series A2021-04-22
Funding rounds
- Series A
- 2021-04-22
Products
- Other
- PEP-010
Loading relationship preview